Evogene Ltd. (EVGN)
NASDAQ·Healthcare·Biotechnology
$0.36
-1.95%
Mkt Cap $3.45M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$2.15
Range $2.15 – $2.15
Implied Upside
+492.6%
Consensus $2.15 vs current $0.36
NASDAQ·Healthcare·Biotechnology
$0.36
-1.95%
Mkt Cap $3.45M
No recent rating data.
Price Target (3 analysts)
$2.15
Range $2.15 – $2.15
+492.6%
Consensus $2.15 vs current $0.36